Disease Specific IPS Lines From Patients With a Genetic or Developmental Basis for Their Renal Disease

Overview

About this study

The purpose of this study is to derive disease specific iPS lines from patients with a genetic or developmental basis for their renal disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients aged 0-100 years with a kidney disease of interest
Subjects aged >18 years who are biologically related to a case individual

Exclusion Criteria:

Unaffected children < 18 years of age who are not clinically diagnosed with a disease of interest
Patients with an allergy to subcutaneous lidocaine or bupivacaine (if undergoing a dermal punch biopsy)
Subjects unable to consent to the study or have a parent/guardian/witness sign on their behalf

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 1/12/24. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Navin Gupta, M.D.	Open for enrollment	Contact information: CRM Biotrust MAYOCLINICBIOTRUST@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Navin Gupta, M.D.

Open for enrollment

Contact information:

CRM Biotrust

MAYOCLINICBIOTRUST@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials